賽諾醫療(688108.SH):產品HT Supreme藥物洗脱支架系統獲得土耳其衞生部註冊批准
格隆匯9月27日丨賽諾醫療(688108.SH)公佈,公司於2022年11月向土耳其衞生部遞交了公司HT
Supreme藥物洗脱支架系統的註冊申報資料。公司於近日收到土耳其衞生部通知,公司HT Supreme藥物洗脱支架系統獲得土耳其衞生部的批准。
藥物洗脱支架系統由藥物洗脱支架和快速交換球囊導管輸送系統組成。藥物洗脱支架以L605鈷鉻合金支架為基體,表面塗覆底部塗層和含藥高分子塗層。底部塗層材料為聚甲基丙烯酸丁酯(PBuMA),該塗層不可降解;藥物塗層由雷帕黴素藥物和聚乳酸-羥基乙酸(PLGA)組成,為可降解塗層。產品經電子束滅菌,一次性使用,貨架有效期1年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.